IE 11 Not Supported

For optimal browsing, we recommend Chrome, Firefox or Safari browsers.

CDC Recommends Pause in J&J Vaccine

Blood clots in six people out of 7 million vaccinations.

Measuring risk is always a tough decision. There are absolutes for some people. One death, one blood clot is too many. See this Washington Post article: “Pause of J&J vaccine threatens to slow U.S. pandemic progress amid rising caseload.” 

Seven million doses of the Johnson & Johnson vaccine have been administered and there have been blood clot issues with six people. I just checked and you are twice as likely to be hit by lightning (1 out of 500,000) than to get a blood clot from the J&J vaccine. 

If we were all in the military and at war, I can tell you it would be a no-brainer — keep administering the vaccine since the dangers from the disease are greater and more likely to impact a person than the blood clotting issue.

BUT, we are not all in the military and we, while at war with the virus, are not in a traditional war. So, I’ll leave the decision-making to the FDA and the CDC. I expect this will be resolved quickly, but, as is the case with the AstraZeneca vaccine, it will give it a black eye that will cause people to avoid getting vaccinated — with that particular vaccine or, in some cases, any vaccine at all. 

Eric Holdeman is a contributing writer for Emergency Management magazine and is the former director of the King County, Wash., Office of Emergency Management.